Bosch has developed a new rapid test for its Vivalytic assay device to detect coronavirus. The test provides a reliable result in 39 minutes and is currently the fastest test in the world.
The new rapid test is designed for use in mobile test centers – at highway service stations or at airports. People who take the test can get a reliable result at the test site.
The test helps to avoid quarantine, relieve labs and make travel and work safer again. “One of the keys in the fight against the coronavirus pandemic is to quickly identify sources of infection. That is why we have focused on continuing our first coronavirus test with an even faster one. This will allow us to quickly calm people’s minds,” says Dr. Volkmar Denner.
Bosch launched the first rapid test for its Vivalytic analysis instrument at the end of March, after just six weeks of development. It simultaneously tests patient samples for the SARS-CoV-2 virus and nine other respiratory diseases in less than two and a half hours. New test is exclusively for SARS-CoV-2.
“With the various tests for coronavirus, we are opening up a range of test scenarios with the Vivalytic device, from full screening to supporting differential diagnosis of diseases with similar symptoms,” says one of the developers. And development at Bosch is still in full swing: from the beginning of October 2020, it will be possible to evaluate five samples simultaneously in one test cartridge and at comparable speed – for the first time in the world.
This way, Bosch increases the available testing capacity by providing fully automated processing of over 160 samples per day with the Vivalytic device. In addition, optimized software will further shorten the time it takes to test SARS-CoV-2 on positive samples over the next few weeks.
The benefits of the Bosch Rapid Test include not only fast analysis, but also ease of use. A sample is taken from the patient’s nose and throat using a swab and placed in a test cartridge. The test cartridge, which already contains all the reagents required for the test, is then inserted into the Vivalytic device for automatic analysis. The Vivalytic assay device is designed to be easy to use, requiring only a short training for medical personnel.
Bosch wants to reach capacity for one million tests by the end of the year. As demand for analysis and rapid test devices remains strong, the company is working closely with its suppliers to maximize productivity and increase supply.